Dr Courtney Olwagen
Senior Scientist
About
Dr Courtney Olwagen is a senior research scientist at the Vaccine and Infectious Diseases Analytics Research Unit (VIDA) of the University of the Witwatersrand. She has been involved in clinical microbiology and infectious disease research for the past 10 years, with a specific focus on reducing under-5 childhood morbidity and mortality. She is the principal investigator on a project that is evaluating the association of HIV infection and density of nasopharyngeal bacterial colonizers in PCV-immunised children and is the co-principal investigator on a grant-funded project investigating the temporal changes of drug-resistant Streptococcus pneumoniae. Her work on pneumococcal disease also encompasses a molecular diagnostic program for Streptococcus pneumonia in which she is the lead scientist. As part of this work, Courtney has developed a nanofluidic assay that can simultaneously detect 90 different pneumococcal serotypes together with other common bacterial and viral respiratory pathogens. The development of this assay has allowed the unit to serotype pneumococcus in several ongoing projects including a clinical trial that is investigating pneumococcal colonisation in children receiving different schedules of different PCV vaccine formulations.
To better understand the interaction of different pathogens causing disease in children, Courtney’s research portfolio also includes studies that are investigating the maternal vaginal microbiome composition that is associated with adverse pregnancy outcomes (including neonatal deaths and stillbirths) and a longitudinal study of the nasopharyngeal microbiome in infants with lower respiratory tract infections. Further, she is the co-principal investigator on a grant-funded study that is applying next-generation sequencing to identify pathogens causing infection-related neonatal deaths and stillbirths.
During her time at Wits VIDA, Courtney’s work has resulted in numerous publications as well as presentations at both international and local conferences. She is the recipient of the Robert Austrian research award and is a member of the Golden Key International Honour Society. She has also reviewed publications for several different scientific journals.
Publications
2023. Metagenomic sequencing of post-mortem tissue samples for the identification of pathogens associated with neonatal deaths.  Nat Commun 14(1):5373
,2023. Streptococcus pneumoniae and other bacterial nasopharyngeal colonization seven years post-introduction of 13-valent pneumococcal conjugate vaccine in South African children.  Int J Infect Dis 134:45-52
,2023. All-cause and pathogen-specific lower respiratory tract infection hospital admissions in children younger than 5 years during the COVID-19 pandemic (2020-22) compared with the pre-pandemic period (2015-19) in South Africa: an observational study.  Lancet Infect Dis 23(9):1031-1041
,2023. In-silico identification of potential inhibitors against FabI protein in Klebsiella pneumoniae.  J Biomol Struct Dyn.
,2023. Optimization of a high-throughput nanofluidic real-time PCR to detect and quantify of 15 bacterial species and 92 Streptococcus pneumoniae serotypes.  Sci Rep 13(1):4588
,2023. Single priming and booster dose of ten-valent and 13-valent pneumococcal conjugate vaccines and Streptococcus pneumoniae colonisation in children in South Africa: a single-centre, open-label, randomised trial.  Lancet Child Adolesc Health 7(5):326-335
,2022. Population genomics of pneumococcal carriage in South Africa following the introduction of the 13-valent pneumococcal conjugate vaccine (PCV13) immunization.  Microb Genom 8.
,2021. High-throughput nanofluidic real-time PCR to discriminate Pneumococcal Conjugate Vaccine (PCV)-associated serogroups 6, 18, and 22 to serotypes using modified oligonucleotides.  Sci Rep 11(1):23728
,2020. Evaluation of the impact of HIV-1 infection and density of common nasopharyngeal bacterial colonizers in South African children immunized with 7-valent pneumococcal conjugate vaccine.  Vaccine 38(7):1762-1769
,2019. Performance of the Biomark HD real-time qPCR System (Fluidigm) for the detection of nasopharyngeal bacterial pathogens and Streptococcus pneumoniae typing.  Sci Rep 9(1):6494
,2018. Review on Clinical and Molecular Epidemiology of Human Rhinovirus-Associated Lower Respiratory Tract Infections in African and Southeast Asian Children.  Pediatr Infect Dis J 37(7):e185-e194
,2018. Evaluation of the association of pneumococcal conjugate vaccine immunization and density of nasopharyngeal bacterial colonization using a multiplex quantitative polymerase chain reaction assay.  Vaccine 36(23):3278-3285
,2017. Use of Multiplex Quantitative PCR To Evaluate the Impact of Pneumococcal Conjugate Vaccine on Nasopharyngeal Pneumococcal Colonization in African Children.  mSphere 2.
,2017. Comparison of traditional culture and molecular qPCR for detection of simultaneous carriage of multiple pneumococcal serotypes in African children.  Sci Rep 7(1):4628
,Publication list retrieved from NCBI using ImpactPubs
.